Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3305148012 | Lomitapide mesilate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3305149016 | Lomitapide mesilate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3305150016 | Lomitapide mesylate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1172501000172117 | mésilate de lomitapide | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1187741000172117 | lomitapidemesilaat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lomitapide mesilate (substance) | Is a | Lomitapide (substance) | false | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Is a | Microsomal triglyceride transfer protein inhibitor | true | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Is modification of (attribute) | Lomitapide (substance) | true | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Has disposition (attribute) | Microsomal triglyceride transfer protein inhibitor (disposition) | true | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Is a | Benzimidazole (substance) | true | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Is a | Fluorene (substance) | true | Inferred relationship | Some | ||
| Lomitapide mesilate (substance) | Is a | Antilipemic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely lomitapide (as lomitapide mesilate) 5 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Lomitapide mesilate (substance) | Inferred relationship | Some | 1 |
| Product containing precisely lomitapide (as lomitapide mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Lomitapide mesilate (substance) | Inferred relationship | Some | 1 |
| Product containing precisely lomitapide (as lomitapide mesilate) 20 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Lomitapide mesilate (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR